Overview

Study of Anlotinib in Patients With Soft Tissue Sarcoma（STS）(ALTER0203)

Status:
Unknown status
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
Compare the effects and safety of Anlotinib with placebo in patients with soft tissue sarcoma.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd